Evidence map›Paper›PMID 40120762›Full record

ArticleJournal of lipid research2025

Apolipoprotein A1 deficiency increases macrophage apoptosis and necrotic core development in atherosclerotic plaques in a Bim-dependent manner.

Alexander S Qian, George E G Kluck, Pei Yu, Leticia Gonzalez, Elizabeth Balint, Bernardo L Trigatti

Abstract read
In one paragraph

Article in Journal of lipid research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alexander S QianThrombosis and Atherosclerosis Research Institute, Centre for Metabolism, Obesity and Diabetes Research, and Department of Biochemistry and Biomedical Sciences, McMaster University and, Hamilton Health Sciences, Hamilton, Ontario, Canada.
George E G KluckThrombosis and Atherosclerosis Research Institute, Centre for Metabolism, Obesity and Diabetes Research, and Department of Biochemistry and Biomedical Sciences, McMaster University and, Hamilton Health Sciences, Hamilton, Ontario, Canada.
Pei YuThrombosis and Atherosclerosis Research Institute, Centre for Metabolism, Obesity and Diabetes Research, and Department of Biochemistry and Biomedical Sciences, McMaster University and, Hamilton Health Sciences, Hamilton, Ontario, Canada.
Leticia GonzalezThrombosis and Atherosclerosis Research Institute, Centre for Metabolism, Obesity and Diabetes Research, and Department of Biochemistry and Biomedical Sciences, McMaster University and, Hamilton Health Sciences, Hamilton, Ontario, Canada.
Elizabeth BalintThrombosis and Atherosclerosis Research Institute, Centre for Metabolism, Obesity and Diabetes Research, and Department of Biochemistry and Biomedical Sciences, McMaster University and, Hamilton Health Sciences, Hamilton, Ontario, Canada.
Bernardo L TrigattiThrombosis and Atherosclerosis Research Institute, Centre for Metabolism, Obesity and Diabetes Research, and Department of Biochemistry and Biomedical Sciences, McMaster University and, Hamilton Health Sciences, Hamilton, Ontario, Canada. Electronic address: trigatt@mcmaster.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In advanced atherosclerotic lesions, macrophage apoptosis contributes to plaque progression and the formation of necrotic cores, rendering plaques vulnerable to rupture. The proapoptotic protein B-cell lymphoma 2 [Bcl-2] interacting mediator of cell death (Bim) plays a crucial role in mediating apoptosis in macrophages under prolonged endoplasmic reticulum stress. HDL has been shown to suppress macrophage apoptosis induced by endoplasmic reticulum stressors. To investigate the impact of apolipoprotein A1 (ApoA1) deficiency, associated with reduced HDL levels, on necrotic core growth and plaque apoptosis, we introduced ApoA1 deficiency into low-density lipoprotein receptor (LDLR) knockout mice and fed them a high-fat diet for 10 weeks. ApoA1-deficient Ldlr KO mice developed advanced plaques characterized by large necrotic cores, increased apoptosis, and elevated Bim expression in macrophages within the plaques. To assess whether deletion of Bim could mitigate this development, mice underwent bone marrow transplantation with bone marrow from either Bim-deficient mice or from mice with a deletion of myeloid-derived Bim driven by LyzM-cre. Inhibiting Bim in all bone marrow-derived cells led to leukocytosis, reductions in plasma cholesterol and triglyceride levels, and decreased plaque apoptosis, necrotic core, and plaque sizes in ApoA1 and Ldlr double-KO mice but not in Ldlr KO mice. Likewise, conditional deletion of Bim in the myeloid compartment of ApoA1 and Ldlr double-KO mice also reduced apoptosis, necrotic core sizes, and plaque sizes, without inducing leukocytosis or lowering plasma cholesterol levels. These findings suggest that ApoA1 deficiency triggers apoptosis in myeloid cells through a Bim-dependent pathway, significantly contributing to the development of necrotic cores and the progression of atherosclerotic plaques.

Indexed as

Apolipoprotein A-IApoptosisBcl-2-Like Protein 11MacrophagesPlaque, AtheroscleroticAnimalsMaleMiceMice, KnockoutNecrosisReceptors, LDLApolipoprotein A-IBcl2l11 protein, mouseBcl-2-Like Protein 11Receptors, LDLapolipoprotein A1apoptosisatherosclerosisHDLmacrophagesmonocytes

Identifiers

PMID40120762
PMCPMC12051063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.